000 | 01814 a2200505 4500 | ||
---|---|---|---|
005 | 20250513205651.0 | ||
264 | 0 | _c20000510 | |
008 | 200005s 0 0 eng d | ||
022 | _a0008-543X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOgilvie, G K | |
245 | 0 | 0 |
_aEffect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. _h[electronic resource] |
260 |
_bCancer _cApr 2000 |
||
300 |
_a1916-28 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArginine _xtherapeutic use |
650 | 0 | 4 |
_aCachexia _xprevention & control |
650 | 0 | 4 | _aDiet |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aDocosahexaenoic Acids _xadministration & dosage |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 |
_aEicosapentaenoic Acid _xadministration & dosage |
650 | 0 | 4 |
_aFatty Acids _xpharmacology |
650 | 0 | 4 |
_aFish Oils _xpharmacology |
650 | 0 | 4 |
_aLactic Acid _xblood |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aFettman, M J | |
700 | 1 | _aMallinckrodt, C H | |
700 | 1 | _aWalton, J A | |
700 | 1 | _aHansen, R A | |
700 | 1 | _aDavenport, D J | |
700 | 1 | _aGross, K L | |
700 | 1 | _aRichardson, K L | |
700 | 1 | _aRogers, Q | |
700 | 1 | _aHand, M S | |
773 | 0 |
_tCancer _gvol. 88 _gno. 8 _gp. 1916-28 |
|
999 |
_c10714036 _d10714036 |